Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase 1

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

tofacitinib / Generic mfg.

NCT00969813: A Safety and Tolerability Study of CP-690,550 in Subjects With Hepatic Impairment and Normal Hepatic Function

Completed

CP-690,550

Pfizer

Hepatic Insufficiency

01/10

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites